Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Asia Pacific Breast Implants Market – Insights

Breast implants are medical devices that are used to augment the size of the breasts, either for cosmetic or reconstruction purposes, following mastectomy or to correct a congenital abnormality. The process is called breast augmentation and involves use of breast implants and fat, called as fat transfer breast augmentation, in order to enhance and improve the size of the breasts.

Statistics:

Asia Pacific breast implants market is estimated to account for US$ 329.5 Mn in terms of value by the end of 2027.

Asia Pacific Breast Implants Market: Drivers

Increasing prevalence of breast cancer is expected to propel growth of Asia Pacific breast implants market over the forecast period. For instance, according to the Union Health Ministry, Government of India, 2018 data, the prevalence of breast cancer is 25.8 per 100,000 women and the mortality rate for the disease is 12.7 per 100,000 women. Moreover, around 17, 97,900 women in India may suffer from breast cancer by 2020.

High preference for highly cohesive silicone breast implants is also expected to aid in growth of the market. Silicone breast implants have high strength silicone gel that is textured with silicone shell. Such implants are thicker and contain more cohesive silicone gel, which eliminates the probability of filler leakage into the body.

China held dominant position in Asia Pacific breast implants market in 2019, accounting for 31.4% share in terms of value, followed by Japan.

Figure 1. Asia Pacific Breast Implants Market Share (%), by Region, 2019

Asian Breast Implants  | Coherent Market Insights

Asia Pacific Breast Implants Market: Restraints

Breast implants may lead to rare type of cancers, which is expected to hinder growth of the market. According to the U.S. FDA, breast implants can lead to anaplastic large cell lymphoma, a rare type of fast-growing non-Hodgkin lymphoma.

Moreover, high cost of breast augmentation is also expected to hamper growth of the market. For instance, in India, the total cost of breast augmentation (including cost of implants and cost of surgery) is around US$ 2,800.

Asia Pacific Breast Implants Market: Opportunities 

Introduction of lightweight breast implants is expected to offer lucrative growth opportunities for players in the market. Such implants can be developed using cohesive gel filler.

Moreover, use of 3D printing molds in developing prosthetic breasts is also expected to aid in growth of the market. For instance, New Zealand-based myReflection uses 3D scanning and 3D printing molds to develop customized prosthetic breasts for cancer patients who have received a mastectomy.

Asian Breast Implants  | Coherent Market Insights

Silicone Breast Implant segment in Asia Pacific breast implants market was valued at US$ 167.3 Mn in 2019 and is expected to reach US$ 297.0 Mn by 2027 at a CAGR of 7.4% during the forecast period.

Market Trends/Key Takeaways

Saline and silicone implants are the most used of implants in the market. However, teardrop or gummy bear implants are gaining rapid preference, owing to increasing preference for natural looking breasts.

The demand for fat transfer breast augmentation is high in the recent times. This is owing to wide perception among women that individual body fat offers a more natural look and feel; and less invasive nature of the procedure.

Asian Breast Implants  | Coherent Market Insights

Asia Pacific Breast Implants Market: Competitive Landscape    

Major players operating in Asia Pacific breast implants market include, Allergan, Plc (Actavis Plc), Mentor Worldwide LLC. (Johnson & Johnson Services, Inc.), GC Aesthetics plc, Sientra, Inc., Groupe Sebbin SAS, Polytech Health & Aesthetics GmbH (Deutsche Beteiligungs AG), Establishment Labs S.A., CollPlant Holdings Ltd., HansBiomed Co., Ltd., Cereplas, and PS Technology Development Limited.

Asia Pacific Breast Implants Market: Key Developments  

Major players in the market are focused on approval and launch of products to enhance their market share. For instance, in November 2018, Polytech Health & Aesthetics GmbH received the CE Mark for Polytech and B-Lite breast implants for another five years.

Players in the market are also focused on adopting partnership strategies to expand their product portfolio. For instance, in November 2019, Evonik, a developer of biomaterials for implantable medical devices, partnered with BellaSeno GmbH, a developer of 3D printed absorbable scaffolds, for the use of a RESOMER bioresorbable polymer for an innovative breast implant technology.

Breast implants are the most commonly used to augment the size of the breasts for cosmetic or reconstruction after mastectomy. There are mainly two types of breasts implants namely saline and silicon implants. Silicone breast implants have high strength silicone gel that is textured with silicone shell. Increasing prevalence of breast cancer is expected to propel growth of Asia Pacific breast implants market over the forecast period. Furthermore, introduction of lightweight breast implants is expected to offer lucrative growth opportunities for players in the market during the forecasted period.

Key features of the study:

  • This report provides in-depth analysis of the Breast Implants market  and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2019–2027), considering 2018 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the Asia Pacific Breast Implants market  based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include, Allergan, Plc (Actavis Plc), Mentor Worldwide LLC. (Johnson & Johnson Services, Inc.), GC Aesthetics plc, Sientra, Inc., Groupe Sebbin SAS, Polytech Health & Aesthetics GmbH (Deutsche Beteiligungs AG), Establishment Labs S.A., CollPlant Holdings Ltd., HansBiomed Co., Ltd., Cereplas, and PS Technology Development Limited.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The Asia Pacific Breast Implants market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Asia Pacific Breast Implants market

Detailed Segmentation:

  • Breast Implants Market, By Product Type:
    • Silicone Breast Implant
    • Saline Breast Implant
  • Breast Implants Market, By Shape:
    • Round Breast Implant
    • Anatomical Breast Implant
  • Breast Implants Market, By Application:
    • Cosmetic Surgery
    • Reconstructive surgery
  • Breast Implants Market, By End User:
    • Hospitals
    • Cosmetic Clinics
  • Breast Implants Market, By Region:
    • China
      • By Product Type:
        • Silicone Breast Implant
        • Saline Breast Implant
      • By Shape
        • Round Breast Implant
        • Anatomical Breast Implant
      • By Application
        • Cosmetic Surgery
        • Reconstructive surgery
      • By End User
        • Hospitals
        • Cosmetic Clinics
    • India
      • By Product Type:
        • Silicone Breast Implant
        • Saline Breast Implant
      • By Shape
        • Round Breast Implant
        • Anatomical Breast Implant
      • By Application
        • Cosmetic Surgery
        • Reconstructive surgery
      • By End User
        • Hospitals
        • Cosmetic Clinics
    • Japan
      • By Product Type:
        • Silicone Breast Implant
        • Saline Breast Implant
      • By Shape
        • Round Breast Implant
        • Anatomical Breast Implant
      • By Application
        • Cosmetic Surgery
        • Reconstructive surgery
      • By End User
        • Hospitals
        • Cosmetic Clinics
    • Australia
      • By Product Type:
        • Silicone Breast Implant
        • Saline Breast Implant
      • By Shape
        • Round Breast Implant
        • Anatomical Breast Implant
      • By Application
        • Cosmetic Surgery
        • Reconstructive surgery
      • By End User
        • Hospitals
        • Cosmetic Clinics
    • South Korea
      • By Product Type:
        • Silicone Breast Implant
        • Saline Breast Implant
      • By Shape
        • Round Breast Implant
        • Anatomical Breast Implant
      • By Application
        • Cosmetic Surgery
        • Reconstructive surgery
      • By End User
        • Hospitals
        • Cosmetic Clinics
    • ASEAN
      • By Product Type:
        • Silicone Breast Implant
        • Saline Breast Implant
      • By Shape
        • Round Breast Implant
        • Anatomical Breast Implant
      • By Application
        • Cosmetic Surgery
        • Reconstructive surgery
      • By End User
        • Hospitals
        • Cosmetic Clinics
    • Rest of APAC
      • By Product Type:
        • Silicone Breast Implant
        • Saline Breast Implant
      • By Shape
        • Round Breast Implant
        • Anatomical Breast Implant
      • By Application
        • Cosmetic Surgery
        • Reconstructive surgery
      • By End User
        • Hospitals
        • Cosmetic Clinics
  • Company Profiles
    • Allergan, Plc (Actavis Plc) *
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Mentor Worldwide LLC (Johnson & Johnson Services, Inc.)
    • GC Aesthetics plc
    • Sientra Inc.
    • Groupe Sebbin SAS
    • Polytech Health & Aesthetics GmbH (Deutsche Beteiligungs AG)
    • Establishment Labs S.A
    • CollPlant Holdings Ltd.
    • HansBiomed Co., Ltd.
    • Cereplas
    • PS Technology Development Limited
  • *” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product Type
      • Market Snippet, By Shape
      • Market Snippets, By Application
      • Market Snippets, By End User
      • Market Snippet, By Region
      • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Key Highlights
    • Product launch
    • PEST Analysis
    • Regulatory Scenario
    • Mergers and Acquisitions
  4. Asia Pacific Breast Implants Market, By Product Type, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Silicone Breast Implant
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Saline Breast Implant
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  5. Asia Pacific Breast Implants Market, By Shape, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Round Breast Implant
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Anatomical Breast Implant
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  6. Asia Pacific Breast Implants Market, By Application, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Cosmetic Surgery
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Reconstructive surgery
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  7. Asia Pacific Breast Implants Market, By End User, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Cosmetic Clinics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  8. Asia Pacific Breast Implants Market, By Region, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, For Regions, 2017–2026
    • China
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Shape, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
    • India
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Shape, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
    • Japan
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Shape, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
    • Australia
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Shape, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
    • South Korea
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Shape, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
    • ASEAN
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Shape, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
    • Rest of APAC
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Shape, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
  9. Competitive Landscape
    • Company Profiles
      • Allergan, Plc (Actavis Plc)
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Mentor Worldwide LLC. (Johnson & Johnson Services, Inc.)
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • GC Aesthetics plc
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Sientra Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Groupe Sebbin SAS
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Polytech Health & Aesthetics GmbH (Deutsche Beteiligungs AG)
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Establishment Labs S.A.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • CollPlant Holdings Ltd.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • HansBiomed Co., Ltd.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Cereplas
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • PS Technology Development Limited
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
  10. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 20 market data tables and 12 figures on “Breast Implants Market – Asia Pacific forecast to 2027”.

Frequently Asked Questions

The global breast implants market is estimated to surpass US$ 1.8 Billion by 2025.
Major players operating in the global breast implants market include Allergen, Inc., Mentor Worldwide LLC, GC Aesthetics Plc, Sientra, Inc., POLYTECH Health and Aesthetics GmBH, Establishment Labs S.A., LABORATORIES ARION, HANSBIOMED Co. Ltd., Groupe Sebbin SAS, and GG Biotechnology Ltd.
Unfavorable reimbursement policies and implant failures are some of the major factors that are expected to hamper growth of the market over the forecast period.
Increasing incidence of breast cancer and rising adoption of cosmetic and aesthetic procedures, globally are some of the major factors that are expected to propel growth of the market over the forecast period.
The global breast implants market is estimated to exhibit a CAGR of 5.1% over the forecast period
Among regions, North Americais expected to hold dominant position in the global breast implants market over the forecast period.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner